Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release

Research output: Contribution to journalArticle

Authors

  • Erica J. Fratz
  • Jerome Clayton
  • Gregory A. Hunter
  • Sarah Ducamp
  • Leonid Breydo
  • Vladimir N. Uversky
  • Jean Charles Deybach
  • Laurent Gouya
  • Hervé Puy
  • Gloria C. Ferreira

External Institution(s)

  • University of South Florida
  • Hôpital Louis Mourier
  • Institut national de la santé et de la recherche médicale
  • Laboratory of Excellence

Details

Original languageEnglish (US)
Pages (from-to)5617-5631
Number of pages15
JournalBiochemistry
Volume54
Issue number36
StatusPublished - Sep 15 2015
Peer-reviewedYes

Abstract

Regulation of 5-aminolevulinate synthase (ALAS) is at the origin of balanced heme production in mammals. Mutations in the C-terminal region of human erythroid-specific ALAS (hALAS2) are associated with X-linked protoporphyria (XLPP), a disease characterized by extreme photosensitivity, with elevated blood concentrations of free protoporphyrin IX and zinc protoporphyrin. To investigate the molecular basis for this disease, recombinant hALAS2 and variants of the enzyme harboring the gain-of-function XLPP mutations were constructed, purified, and analyzed kinetically, spectroscopically, and thermodynamically. Enhanced activities of the XLPP variants resulted from increases in the rate at which the product 5-aminolevulinate (ALA) was released from the enzyme. Circular dichroism spectroscopy revealed that the XLPP mutations altered the microenvironment of the pyridoxal 5′-phosphate cofactor, which underwent further and specific alterations upon succinyl-CoA binding. Transient kinetic analyses of the variant-catalyzed reactions and protein fluorescence quenching upon binding of ALA to the XLPP variants demonstrated that the protein conformational transition step associated with product release was predominantly affected. Of relevance is the fact that XLPP could also be modeled in cell culture. We propose that (1) the XLPP mutations destabilize the succinyl-CoA-induced hALAS2 closed conformation and thus accelerate ALA release, (2) the extended C-terminus of wild-type mammalian ALAS2 provides a regulatory role that allows for allosteric modulation of activity, thereby controlling the rate of erythroid heme biosynthesis, and (3) this control is disrupted in XLPP, resulting in porphyrin accumulation.

Citation formats

APA

Harvard

Fratz, EJ, Clayton, J, Hunter, GA, Ducamp, S, Breydo, L, Uversky, VN, Deybach, JC, Gouya, L, Puy, H & Ferreira, GC 2015, 'Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release', Biochemistry, vol. 54, no. 36, pp. 5617-5631. https://doi.org/10.1021/acs.biochem.5b00407